Archer Materials Limited (ASX:AXE) Advances Biochip Technology
Archer Materials Limited (ASX:AXE) has progressed its Biochip technology, improving accuracy for chronic kidney disease testing.
Archer Materials Limited (ASX:AXE) has progressed its Biochip technology, improving accuracy for chronic kidney disease testing.
Southern Cross Gold Ltd (ASX:SXG) announced significant gold intercepts at its Sunday Creek project, expanding its known mineralisation zone.
Cann Group Limited (ASX: CAN) raises $2 million to support its growth initiatives through a successful entitlement offer.
Medallion Metals reports a significant high-grade gold intercept at Kundip, aiming for near-term production opportunities.
Dalrymple Bay Infrastructure (ASX:DBI) announces a Q3-24 distribution of 5.625 cps, aligned with their guidance for FY-24.
Aspermont (ASX:ASP) reports a 9% revenue decline and a 43% increase in net loss for FY2024.
Wildcat Resources (ASX:WC8) confirms Australia’s largest undeveloped lithium resource at 74.1Mt, enhancing its position in the global market.
Hastings Technology Metals signs an MOU with Saudi Arabia to establish a rare earths processing supply chain as part of their GSCRI program.
Rumble Resources Ltd partners with Bain and MEGA for Western Queen development, aiming for early cash flow and resource growth.
Fisher & Paykel Healthcare reports record revenue and profit for 1H FY2025, with an interim dividend announcement.